Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-12

FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)

View source ↗

Summary

FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) from Fresenius Medical Care Renal Therapies Group, LLC, potentially updating its…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VELPHORO (sucroferric oxyhydroxide)

Snippet

SUPPL AP for VELPHORO (SUCROFERRIC OXYHYDROXIDE)